Ralph Kirk

884 total citations · 1 hit paper
8 papers, 771 citations indexed

About

Ralph Kirk is a scholar working on Molecular Biology, Molecular Medicine and Microbiology. According to data from OpenAlex, Ralph Kirk has authored 8 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Molecular Medicine and 2 papers in Microbiology. Recurrent topics in Ralph Kirk's work include Reproductive tract infections research (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Ralph Kirk is often cited by papers focused on Reproductive tract infections research (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Ralph Kirk collaborates with scholars based in United Kingdom and Italy. Ralph Kirk's co-authors include Darren Bradshaw, Ev Stöckel, Neil Campbell, Bien Tan, Yaroslav Z. Khimyak, Colin D. Wood, Abbie Trewin, Matthew J. Rosseinsky, Andrew I. Cooper and Hongjun Niu and has published in prestigious journals such as Chemistry of Materials, Antimicrobial Agents and Chemotherapy and British Journal of Cancer.

In The Last Decade

Ralph Kirk

8 papers receiving 747 citations

Hit Papers

Hydrogen Storage in Microporous Hypercrosslinked Organic ... 2007 2026 2013 2019 2007 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Kirk United Kingdom 7 578 449 303 66 53 8 771
Vandana Gupta India 8 160 0.3× 213 0.5× 35 0.1× 49 0.7× 42 0.8× 12 478
Jordi Espín Switzerland 10 375 0.6× 509 1.1× 117 0.4× 58 0.9× 44 0.8× 23 896
Michele Gargano Italy 17 344 0.6× 177 0.4× 164 0.5× 102 1.5× 248 4.7× 66 1.1k
Yumeng Cui China 14 375 0.6× 282 0.6× 54 0.2× 116 1.8× 41 0.8× 44 661
Yimeng Cao China 12 287 0.5× 222 0.5× 26 0.1× 123 1.9× 50 0.9× 15 579
Yangyang Yuan China 18 533 0.9× 669 1.5× 141 0.5× 40 0.6× 67 1.3× 45 919
Alessia Tombesi Italy 14 307 0.5× 334 0.7× 62 0.2× 43 0.7× 190 3.6× 35 784
Mei Xiang China 17 214 0.4× 100 0.2× 218 0.7× 70 1.1× 116 2.2× 45 643
Douglas T. Genna United States 11 381 0.7× 485 1.1× 47 0.2× 43 0.7× 206 3.9× 25 763
Connor J. R. Wells United Kingdom 10 288 0.5× 286 0.6× 17 0.1× 43 0.7× 42 0.8× 13 559

Countries citing papers authored by Ralph Kirk

Since Specialization
Citations

This map shows the geographic impact of Ralph Kirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Kirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Kirk more than expected).

Fields of papers citing papers by Ralph Kirk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Kirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Kirk. The network helps show where Ralph Kirk may publish in the future.

Co-authorship network of co-authors of Ralph Kirk

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Kirk. A scholar is included among the top collaborators of Ralph Kirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Kirk. Ralph Kirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kirk, Ralph, Matilda Bingham, Paul Doyle, et al.. (2020). Novel C-7 carbon substituted fourth generation fluoroquinolones targeting N. Gonorrhoeae infections. Bioorganic & Medicinal Chemistry Letters. 30(20). 127428–127428. 3 indexed citations
2.
Savage, Victoria J., Cédric Charrier, Anne‐Marie Salisbury, et al.. (2016). Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IV. Journal of Antimicrobial Chemotherapy. 71(7). 1905–1913. 22 indexed citations
3.
Savage, Victoria J., Cédric Charrier, Anne‐Marie Salisbury, et al.. (2016). Efficacy of a Novel Tricyclic Topoisomerase Inhibitor in a Murine Model of Neisseria gonorrhoeae Infection. Antimicrobial Agents and Chemotherapy. 60(9). 5592–5594. 7 indexed citations
4.
Festuccia, Claudio, Giovanni Luca Gravina, Andrea Mancini, et al.. (2014). Trifluoroibuprofen Inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in vivo Tumor Growth in Aggressive Prostate Cancer Models. Anti-Cancer Agents in Medicinal Chemistry. 14(7). 1031–1041. 20 indexed citations
5.
Carnell, Andrew J., et al.. (2013). Inhibition of Human α‐Methylacyl CoA Racemase (AMACR): a Target for Prostate Cancer. ChemMedChem. 8(10). 1643–1647. 26 indexed citations
6.
Wood, Colin D., Bien Tan, Abbie Trewin, et al.. (2007). Hydrogen Storage in Microporous Hypercrosslinked Organic Polymer Networks. Chemistry of Materials. 19(8). 2034–2048. 610 indexed citations breakdown →
7.
Kirk, Ralph, et al.. (1962). Human sparganosis in Hong Kong.. PubMed. 65. 133–8. 6 indexed citations
8.
Muir, C. S. & Ralph Kirk. (1960). Betel, Tobacco, and Cancer of the Mouth. British Journal of Cancer. 14(4). 597–608. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026